Related Experiment Video
Updated: Jul 18, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
Hippocampal sclerosis dementia differs from hippocampal sclerosis in frontal lobe degeneration
Catalina Amador-Ortiz1, Zeshan Ahmed, Cynthia Zehr
1Department of Pathology (Neuropathology) and Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL, USA.
Insights
Hippocampal sclerosis dementia (HSD) differs from hippocampal sclerosis (HS) in frontotemporal lobar degeneration. HSD shows greater neuronal loss, synaptic loss, and gliosis, particularly in older individuals.
Area of Science:
- Neuropathology
- Neurodegenerative Diseases
Background:
- Hippocampal sclerosis (HS) involves neuronal loss and gliosis in the hippocampus, linked to various neurodegenerative disorders.
- Hippocampal sclerosis dementia (HSD) presents without other associated pathologies.
- Systematic comparison of HSD and HS within frontotemporal lobar degeneration with ubiquitin immunoreactive inclusions (FTLD-U) is lacking.
Purpose of the Study:
- To investigate the distinct neuropathological features of HSD compared to HS associated with FTLD-U.
Main Methods:
- Studied eight HSD cases and ten HS with FTLD-U cases using Nissl and PAS stains.
- Immunohistochemistry for glial fibrillary acidic protein, HLA-DR, synaptophysin, and 4-R tau.
- Image analysis quantified immunoreactivity in hippocampal CA1 and subiculum.
Main Results:
- HSD cases were more frequent in the elderly.
- HSD exhibited more significant neuronal and synaptic loss compared to HS with FTLD-U.
- Greater reactive gliosis was observed in HSD.
- Corpora amylacea were more frequent in HSD, while argyrophilic grains showed no difference.
Conclusions:
- Hippocampal sclerosis dementia (HSD) is neuropathologically distinct from HS associated with FTLD-U.
- HSD is characterized by more severe neuronal and synaptic degeneration and gliosis.
- These findings highlight key differences in the pathological profiles of these conditions.
Abstract:
Hippocampal sclerosis (HS) is characterized by selective neuronal loss and gliosis in CA1 and the subiculum and has been associated with several disorders, including Alzheimer's disease, frontotemporal lobar degeneration with ubiquitin immunoreactive inclusions (FTLD-U), vascular dementia and some tauopathies. In some cases, HS is not associated with other degenerative pathologies. Such cases are sometimes referred to as HS dementia (HSD). Differences between HSD and HS in the setting of FTLD-U have not been systematically investigated. To this end, eight cases of HSD and ten cases of HS associated with FTLD-U were studied with Nissl and periodic acid-Schiff stains to assess neuronal loss and corpora amylacea, respectively. Sections were immunostained with antibodies to glial fibrillary acidic protein, HLA-DR and synaptophysin and immunoreactivity was measured with image analysis in CA1 and the subiculum of each case. Additionally, sections were immunostained with antibodies to 4-R tau to determine the presence of argyrophilic grains. HSD was different from HS associated with FTLD-U. Specifically, it was more common in the elderly, and it was associated with more marked neuronal and synaptic loss and with greater reactive gliosis. Corpora amylacea tended to be more frequent in HSD than in FTLD-U, but there was no difference in frequency of argyrophilic grains.
Related Concept Videos
Dementia l: Introduction
Alzheimer Disease ll: Pathophysiology
Role of Hippocampus in Memory
Alzheimer Disease l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia
The progression of dementia is generally gradual.

